These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 27595449)

  • 1. Antibodies to HBV surface antigen in relation to interferon-λ3 in hemodialysis patients.
    Grzegorzewska AE; Świderska MK; Mostowska A; Warchoł W; Jagodziński PP
    Vaccine; 2016 Sep; 34(41):4866-4874. PubMed ID: 27595449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of interferon λ3 gene polymorphisms, rs8099917 and rs12979860, on response to hepatitis B virus vaccination and hepatitis B or C virus infections among hemodialysis patients.
    Grzegorzewska AE; Jodłowska E; Mostowska A; Jagodziński P
    Pol Arch Med Wewn; 2015; 125(12):894-902. PubMed ID: 26658164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating Interferon-
    Grzegorzewska AE; Świderska MK; Mostowska A; Jagodziński PP
    Biomed Res Int; 2017; 2017():3713025. PubMed ID: 29226133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlations of indoleamine 2,3-dioxygenase, interferon-λ3, and anti-HBs antibodies in hemodialysis patients.
    Grzegorzewska AE; Winnicka H; Warchoł W; Mostowska A; Jagodziński PP
    Vaccine; 2018 Jul; 36(30):4454-4461. PubMed ID: 29935858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating interferon-λ3 and post-vaccination antibodies against the surface antigen of hepatitis B virus in hemodialysis patients exposed to hepatitis E virus.
    Grzegorzewska AE; Świderska MK; Winnicka H; Niepolski L; Bura M; Łagiedo-Żelazowska M; Jagodziński PP
    Cytokine; 2019 Nov; 123():154766. PubMed ID: 31279176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of the interleukin-12 polymorphic variants with the development of antibodies to surface antigen of hepatitis B virus in hemodialysis patients in response to vaccination or infection.
    Grzegorzewska AE; Wobszal PM; Sowińska A; Mostowska A; Jagodziński PP
    Mol Biol Rep; 2013 Dec; 40(12):6899-911. PubMed ID: 24158609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interferon-λ3 as a Predictor of Survival in Hemodialysis Patients.
    Grzegorzewska AE; Swiderska MK; Warchol W
    Curr Mol Med; 2018; 18(4):207-215. PubMed ID: 30259815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Titers of antibodies to the surface antigen of hepatitis B virus after vaccination in relation to immunity-related gene variants. A prospective study among hemodialysis patients.
    Jodłowska-Siewert E; Jagodziński PP; Grzegorzewska AE
    Pol Arch Intern Med; 2017 Aug; 127(7-8):481-489. PubMed ID: 28817541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymorphism rs368234815 of interferon-λ4 gene and generation of antibodies to hepatitis B virus surface antigen in extracorporeal dialysis patients.
    Grzegorzewska AE; Świderska MK; Marcinkowski W; Mostowska A; Jagodziński PP
    Expert Rev Vaccines; 2020 Mar; 19(3):293-303. PubMed ID: 32228249
    [No Abstract]   [Full Text] [Related]  

  • 10. IL4R and IL13 polymorphic variants and development of antibodies to surface antigen of hepatitis B virus in hemodialysis patients in response to HBV vaccination or infection.
    Grzegorzewska AE; Pajzderski D; Sowińska A; Mostowska A; Jagodziński PP
    Vaccine; 2013 Apr; 31(14):1766-70. PubMed ID: 23462527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum IFN-λ3 Levels Correlate with Serum Hepatitis C Virus RNA Levels in Symptomatic Patients with Acute Hepatitis C.
    Imoto S; Kim SR; Amano K; Iio E; Yoon S; Hirohata S; Yano Y; Ishikawa T; Katsushima S; Komeda T; Fukunaga T; Chung H; Kokuryu H; Horie Y; Hatae T; Fujinami A; Kim SK; Kudo M; Tanaka Y
    Dig Dis; 2017; 35(6):531-540. PubMed ID: 29040985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of a robust T- and B-cell immune response in non- and low-responders to conventional vaccination against hepatitis B by using a third generation PreS/S vaccine.
    Krawczyk A; Ludwig C; Jochum C; Fiedler M; Heinemann FM; Shouval D; Roggendorf M; Roggendorf H; Lindemann M
    Vaccine; 2014 Sep; 32(39):5077-82. PubMed ID: 24975813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Levamisole treatment enhances protective antibody response to hepatitis B vaccination in hemodialysis patients.
    Kayataş M
    Artif Organs; 2002 Jun; 26(6):492-6. PubMed ID: 12072104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of hepatitis B surface antibody decay rates after vaccination between hemodialysis and peritoneal dialysis patients.
    Lin SY; Liu JH; Lin CC; Wang SM; Tsai CA; Chou CY; Kuo HL; Wang IK; Liu YL; Lin HH; Huang CC
    Vaccine; 2011 May; 29(21):3738-41. PubMed ID: 21458609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The hepatitis B vaccine protects re-exposed health care workers, but does not provide sterilizing immunity.
    Werner JM; Abdalla A; Gara N; Ghany MG; Rehermann B
    Gastroenterology; 2013 Nov; 145(5):1026-34. PubMed ID: 23916846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of hepatitis B immunity in hemodialysis patients acquired either naturally or after vaccination.
    Tsouchnikas I; Dounousi E; Xanthopoulou K; Papakonstantinou S; Thomoglou V; Tsakiris D
    Clin Nephrol; 2007 Oct; 68(4):228-34. PubMed ID: 17969490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Persistence of protection to hepatitis B vaccine and response to booster dose among children and adolescents in Dakahleya- Egypt.
    Salama II; Sami SM; Salama SI; Foud WA; Abdel Hamid AT; Said ZN
    Egypt J Immunol; 2014; 21(1):13-26. PubMed ID: 25204041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibodies to hepatitis B virus surface antigen and survival of hemodialysis patients - a prospective study.
    Grzegorzewska AE; Świderska MK; Warchoł W
    Expert Rev Vaccines; 2016 Aug; 15(8):1063-74. PubMed ID: 27166852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relative indoleamine 2,3-dioxygenase transcript level concerning anti-HBs titers in response to HBV vaccination in hemodialysis patients.
    Grzegorzewska AE; Frycz BA; Winnicka H; Warchoł W; Jagodziński PP
    Expert Rev Vaccines; 2018 Oct; 17(10):947-953. PubMed ID: 30251561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is anti-hepatitis B virus (HBV) immunization successful in elderly hemodialysis (HD) patients?
    Jadoul M; Goubau P
    Clin Nephrol; 2002 Oct; 58(4):301-4. PubMed ID: 12400846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.